- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00116766
Field Evaluation of Plant-based Mosquito Control
Field Evaluation of Malaria Vector Control Using Traditional Plant-based Anti-mosquito Measures in Yunnan Province, P.R. China
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction
One of the greatest challenges to those planning vector control programmes in developing Countries is the provision of cover to those populations in remote or isolated areas. Commonly, it is these communities which bear the greatest burden of disease due to location and inaccessibility to local health care. Yunnan Province is a good example of such problems. The border region with Laos, Myanmar and Vietnam contributes a high proportion of all malaria cases in the whole of China, yet few if any disease control initiatives cover the rural minority peoples and migrant workers who inhabit the region. Comprehensive ethnobotanical surveys in the area have shown many of the 25 minority peoples living in isolated communities already use traditional herbal forms of mosquito control utilising several of the abundant species in the particularly diverse local environment. Having identified a number of potentially useful plant species being used, in terms of their availability, sustainability, low cost (free) and known chemical constituents, the investigators and the local Chinese malaria control officials consider a phase II evaluation of the most promising candidates is justified. In particular, 4 widely used plants are traditionally used as fumigants to reduce / prevent mosquitoes entering houses, either by burning dried or fresh material on the indoor cooking fires each evening, or by spraying tinctures around entry sites like eaves & windows. Due to the method of use, it would be very difficult to simulate this in the laboratory, so a simple means of field evaluation has been chosen.
Materials
The ethnobotanical survey revealed the following plant species as candidates for further study; Artemesia argyi, Eucalyptus robusta, Eupatorium odoratum, Cinnamomum glanduliferum
Each of these plant species occurs naturally in abundance in the region and collection will have no significant environmental impact. Moderate amounts (approx 1 Kg) sufficient for each study will be collected locally in each field site prior to (if used dried) or at the start of each experiment (fresh).
Methods
Plants will be evaluated under natural user conditions in a randomised and controlled manner in villages in Xishuangbanna Region, Yunnan, PR China. Village- based studies of several other mosquito control methods have already been successfully undertaken in this region by the LSHTM and YIPD team. Villages belonging to one of the ethnic groups using each traditional method will be selected according to agreement between local health workers from YIPD and the village elders, availability of plant species, and preliminary survey of vector species collected indoors with CDC traps. A different village will be selected for each plant being evaluated. After collecting background entomological data, 6 houses matched for baseline parameters (such as occupancy level, location, construction & animal proximity) and being evenly spaced among others in the village (to reduce diversion effects) will be enrolled into the study. On any one night, 2 will be allocated treatment (use of plant), 2 will be allocated hay (used for cattle bedding) as a negative control, and 2 will be left unused (to reduce any residual effects). In each case the treatment or control group will be instructed to place pre-prepared batches of plant material (weighed fresh or dry depending upon type) onto their cooking fire in the traditional manner in the early evening. Commercial CDC traps (BioQuip Inc., USA) will be used in / beside the sleeping areas of each house from 1 hour before sunset to early morning. Catches will be identified by local vector experts each day to record species and number. House treatment will be rotated each night using latin square principles to achieve a minimum of 12 replicates of each treatment in every house (36 nights duration, 216 trap/nights), and will take place during the rainy (malaria) season (July - Nov 2005) when both plants and vector levels are highest.
In the case of C. glanduliferum, the plant extract (or hay extract) will be sprayed at a predetermined rate onto eaves & doors / windows in the traditional manner following the same principles. Efficacy will be determined by comparing mosquito species / numbers caught in control & treatment houses using appropriate statistical analysis & ANOVA methodologies.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Existing use of traditional plant-based methods of mosquito control
Exclusion Criteria:
- Known allergy to plants in use
- Respiratory illness
- Infants under 6 years in house
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction in vector mosquitoes entering houses
Time Frame: per night over 45 nights
|
per night over 45 nights
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduced human biting by mosquitoes
Time Frame: per night over 45 nights
|
per night over 45 nights
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nigel Hill, PhD, London School of Hygiene and Tropical Medicine
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DIF28
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arbovirus Infections
-
Institut PasteurCompleted
-
Institut PasteurInstitut Pasteur of New CaledoniaRecruiting
-
University of Notre DameUniversity of California, DavisCompleted
-
PATHInternational Centre for Diarrhoeal Disease Research, BangladeshCompleted
-
University of Notre DameUniversity of Washington; SC Johnson, A Family Company; fhiClinical; Ministry of... and other collaboratorsRecruitingArbovirus InfectionsSri Lanka
-
University of LiverpoolCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedJapanese EncephalitisKorea, Republic of
-
Sanofi Pasteur, a Sanofi CompanyCompletedJapanese EncephalitisKorea, Republic of
-
Sanofi Pasteur, a Sanofi CompanyNational Institute of Hygiene and Epidemiology, VietnamCompleted
-
PATHMahidol University; Ministry of Health of Sri Lanka; Quintiles SingaporeCompletedJapanese EncephalitisSri Lanka
Clinical Trials on anti-mosquito plant use
-
Peking University Third HospitalRecruitingPancreatic PseudocystChina
-
Peking University Third HospitalRecruitingProliferative Diabetic RetinopathyChina
-
Raisio GroupMedfiles Ltd., FinlandCompletedDyslipidemias | Hypercholesterolemia | Hyperlipidemias
-
University of BernNot yet recruiting
-
Sanaria Inc.Radboud University Medical Center; Leiden University Medical CenterCompleted
-
Physicians Committee for Responsible MedicineActive, not recruitingWeight Loss | PreDiabetes | Blood Pressure | Diabete Mellitus | Lipid DisorderUnited States
-
University Hospital, Basel, SwitzerlandLondon School of Hygiene and Tropical Medicine; Swiss National Science Foundation and other collaboratorsActive, not recruitingHuman Immunodeficiency Virus (HIV) InfectionLesotho, Malawi
-
University Hospital TuebingenRobert Bosch Gesellschaft für Medizinische Forschung mbHRecruitingBreast Cancer | Hand-Foot SyndromeGermany
-
Charite University, Berlin, GermanyLuxembourg Centre for Systems Biomedicine; Braunschweig Integrated Centre of...TerminatedRheumatoid ArthritisGermany
-
Korean South West East Gastric Surgery GroupCompletedGastric Cancer | Complication of Surgical ProcedureKorea, Republic of